Ascentage Pharma Group
Manufacturing · China · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Xinghu Street Building B7 218 Industrial...Phone Number
(301) 291-5658Website
www.ascentagepharma.comRevenue
$80.9 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Ascentage Pharma Group
Ascentage Pharma is a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases. The company focuses on developing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. Founded in 2009, Ascentage Pharma is headquartered in Suzhou, China.Explore more
Ascentage Pharma Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ascentage Pharma Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Ascentage Pharma Group, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Ascentage Pharma Group launches new products
Check if Ascentage Pharma Group has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Ascentage Pharma Group has new funding data
Congratulate Masked Content for being promoted to Masked Content at Ascentage Pharma Group
Check out if Ascentage Pharma Group is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Ascentage Pharma Group recently announced quarterly report
Click to see if Ascentage Pharma Group had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Ascentage Pharma Group as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Ascentage Pharma Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ascentage Pharma Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ascentage Pharma Group.
Ascentage Pharma Group financials insights
Gather financial insights about Ascentage Pharma Group, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series A
$15.1M
2016
Series B
$72M
Ascentage Pharma Group Tech Stack
A closer look at the technologies used by Ascentage Pharma Group
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Ascentage Pharma Group News & Media
Stocks To Watch In Gloomy Market — Including This Breakout IPO
In troubled market, insurance stocks, gold, energy, education and this hot Chinese biotech IPO lead this brigade of stocks to watch.Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference
ROCKVILLE, Md. and SUZHOU, China, Dec. 26, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that its...Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has...Live from ASH 2024 | Ascentage Pharma Releases Updated Data of Bcl-2 Inhibitor Lisaftoclax in MDS that Demonstrates Potential Clinical Benefits and Favorable Safety
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has released the follow-up safety and efficacy data of the company's investigational Bcl-2 selective inhibitor, lisaftoclax (APG-2575), in combination with azacitidine (AZA) for the treatment of patients with myelodys
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ascentage Pharma Group
Sign Up For FreeTo access detailed company insights
Ascentage Pharma is a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases. The company focuses on developing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. Founded in 2009, Ascentage Pharma is head... Read More
